Testing effectiveness (Phase 2)Study completedNCT01428128
What this trial is testing
Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector
Who this might be right for
Cancer Other Than Leukemia
The University of Texas Health Science Center at San Antonio 50